JP2024540061A5 - - Google Patents
Info
- Publication number
- JP2024540061A5 JP2024540061A5 JP2024525251A JP2024525251A JP2024540061A5 JP 2024540061 A5 JP2024540061 A5 JP 2024540061A5 JP 2024525251 A JP2024525251 A JP 2024525251A JP 2024525251 A JP2024525251 A JP 2024525251A JP 2024540061 A5 JP2024540061 A5 JP 2024540061A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- nov
- seq
- antigen
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163272439P | 2021-10-27 | 2021-10-27 | |
| US63/272,439 | 2021-10-27 | ||
| PCT/US2022/078753 WO2023076977A1 (en) | 2021-10-27 | 2022-10-27 | Norovirus vaccine and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540061A JP2024540061A (ja) | 2024-10-31 |
| JP2024540061A5 true JP2024540061A5 (https=) | 2025-11-06 |
Family
ID=86158598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525251A Pending JP2024540061A (ja) | 2021-10-27 | 2022-10-27 | ノロウイルスワクチン及び使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250018021A1 (https=) |
| EP (1) | EP4422681A4 (https=) |
| JP (1) | JP2024540061A (https=) |
| KR (1) | KR20240111822A (https=) |
| CN (1) | CN118450902A (https=) |
| AU (1) | AU2022379626A1 (https=) |
| CA (1) | CA3235832A1 (https=) |
| IL (1) | IL312261A (https=) |
| MX (1) | MX2024005194A (https=) |
| WO (1) | WO2023076977A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4554617A1 (en) * | 2022-07-13 | 2025-05-21 | ModernaTX, Inc. | Norovirus mrna vaccines |
| KR20260008117A (ko) * | 2023-05-08 | 2026-01-15 | 머크 샤프 앤드 돔 엘엘씨 | 노로바이러스 vp1 항원을 코딩하는 폴리뉴클레오티드 및 그의 용도 |
| KR20250123985A (ko) * | 2024-02-08 | 2025-08-19 | (주)한국바이오셀프 | 노로바이러스 GII mRNA를 포함하는 백신 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011276328C1 (en) * | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| US20160185826A1 (en) * | 2014-08-07 | 2016-06-30 | Medigen Biotechnology Corp. | Virus-like particle vaccines |
| EP4631970A3 (en) * | 2016-05-04 | 2026-01-07 | CureVac SE | Nucleic acid molecules and uses thereof |
| WO2019104439A1 (en) * | 2017-11-30 | 2019-06-06 | Medicago Inc. | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins |
| US20250002539A1 (en) * | 2021-07-26 | 2025-01-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus chimeric therapeutics |
-
2022
- 2022-10-27 JP JP2024525251A patent/JP2024540061A/ja active Pending
- 2022-10-27 AU AU2022379626A patent/AU2022379626A1/en active Pending
- 2022-10-27 CN CN202280086321.0A patent/CN118450902A/zh active Pending
- 2022-10-27 EP EP22888483.9A patent/EP4422681A4/en active Pending
- 2022-10-27 US US18/705,288 patent/US20250018021A1/en active Pending
- 2022-10-27 IL IL312261A patent/IL312261A/en unknown
- 2022-10-27 MX MX2024005194A patent/MX2024005194A/es unknown
- 2022-10-27 KR KR1020247017131A patent/KR20240111822A/ko active Pending
- 2022-10-27 CA CA3235832A patent/CA3235832A1/en active Pending
- 2022-10-27 WO PCT/US2022/078753 patent/WO2023076977A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540061A5 (https=) | ||
| US11517584B2 (en) | RNAi agents for Hepatitis B virus infection | |
| CN103864904A (zh) | 基于埃博拉病毒包膜蛋白的抗原片段、截短体及应用 | |
| Zhang et al. | Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot‐and‐mouth disease virus | |
| Spitsin et al. | Expression of alfalfa mosaic virus coat protein in tobacco mosaic virus (TMV) deficient in the production of its native coat protein supports long-distance movement of a chimeric TMV | |
| US11613750B2 (en) | Methods of reducing virus molecule levels | |
| CN114437185B (zh) | 冠状病毒三聚体亚单位疫苗及其应用 | |
| JP2023522154A5 (https=) | ||
| CN116171168A (zh) | 通过靶向抗原表达增强免疫应答 | |
| JP2023086734A5 (https=) | ||
| WO2025040122A1 (zh) | 一种β冠状病毒重组嵌合抗原、其制备方法及应用 | |
| CN117603920A (zh) | 一种表达血清11型禽腺病毒Fiber蛋白的重组血清4型禽腺病毒及其构建方法和应用 | |
| CN115989321B (zh) | 病毒制剂、用于配制病毒制剂的溶液及其用途 | |
| JP2022522166A5 (https=) | ||
| US9029117B2 (en) | Modified rodent parvovirus capable of propagating and spreading through human gliomas | |
| KR20250067065A (ko) | 재조합 sfts 바이러스 기반 2가 백신 조성물 | |
| TW202231869A (zh) | mRNA奈米膠囊及其用於製備抗病毒藥物的用途 | |
| Vandepol et al. | Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection | |
| JP2024525578A5 (https=) | ||
| JP2024523329A5 (https=) | ||
| CN115850520A (zh) | 新型结核病亚单位疫苗al的制备方法和应用 | |
| US8691959B2 (en) | Plasmids with immunological action | |
| CN107022007A (zh) | 基于马尔堡病毒包膜蛋白的抗原片段、截短体及应用 | |
| WO2022143282A1 (zh) | 诺如病毒病毒样颗粒、免疫组合物或试剂盒及其用途 | |
| CN116444629B (zh) | 一种中东呼吸综合征冠状病毒的重组蛋白及疫苗 |